These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9952038)

  • 1. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice.
    Sparks JA; Pauly JR
    Psychopharmacology (Berl); 1999 Jan; 141(2):145-53. PubMed ID: 9952038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
    Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
    Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.
    McCallum SE; Collins AC; Paylor R; Marks MJ
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):314-27. PubMed ID: 16001112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice.
    Robinson SF; Grun EU; Pauly JR; Collins AC
    Pharmacol Biochem Behav; 1996 Jul; 54(3):587-93. PubMed ID: 8743633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial and full deletion of nicotinic acetylcholine receptor α4 and β2 subunits reduces sensitivity to acute nicotine administration and development of tolerance following chronic nicotine administration.
    Marks MJ; Loetz E; Ortiz NC; Herder PA; Collins AC
    Behav Pharmacol; 2020 Oct; 31(7):688-701. PubMed ID: 32568759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test.
    Andreasen JT; Nielsen EO; Redrobe JP
    Psychopharmacology (Berl); 2009 Aug; 205(3):517-28. PubMed ID: 19452140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice.
    Levin ED; Petro A; Rezvani AH; Pollard N; Christopher NC; Strauss M; Avery J; Nicholson J; Rose JE
    Behav Brain Res; 2009 Jan; 196(2):207-13. PubMed ID: 18831991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors.
    Pubill D; Garcia-Ratés S; Camarasa J; Escubedo E
    Neurotoxicology; 2013 Mar; 35():41-9. PubMed ID: 23261423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration.
    King SL; Caldarone BJ; Picciotto MR
    Neuropharmacology; 2004; 47 Suppl 1():132-9. PubMed ID: 15464132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment.
    Pietilä K; Lähde T; Attila M; Ahtee L; Nordberg A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):176-82. PubMed ID: 9521491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites.
    Ulrich YM; Hargreaves KM; Flores CM
    Neuropharmacology; 1997 Aug; 36(8):1119-25. PubMed ID: 9294978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic nicotine pretreatment is sufficient to upregulate α4* nicotinic receptors and increase oral nicotine self-administration in mice.
    Renda A; Nashmi R
    BMC Neurosci; 2014 Jul; 15():89. PubMed ID: 25038610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal variation in nicotine sensitivity in mice: role of genetic background and melatonin.
    Mexal S; Horton WJ; Crouch EL; Maier SI; Wilkinson AL; Marsolek M; Stitzel JA
    Neuropharmacology; 2012 Nov; 63(6):966-73. PubMed ID: 22820272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE; Loetz EC; Marks MJ
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine Enhances the Hypnotic and Hypothermic Effects of Alcohol in the Mouse.
    Slater CA; Jackson A; Muldoon PP; Dawson A; O'Brien M; Soll LG; Abdullah R; Carroll FI; Tapper AR; Miles MF; Banks ML; Bettinger JC; Damaj IM
    Alcohol Clin Exp Res; 2016 Jan; 40(1):62-72. PubMed ID: 26727524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.
    Marks MJ; Pauly JR; Gross SD; Deneris ES; Hermans-Borgmeyer I; Heinemann SF; Collins AC
    J Neurosci; 1992 Jul; 12(7):2765-84. PubMed ID: 1613557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.
    Marks MJ; O'Neill HC; Wynalda-Camozzi KM; Ortiz NC; Simmons EE; Short CA; Butt CM; McIntosh JM; Grady SR
    Neuropharmacology; 2015 Dec; 99():142-55. PubMed ID: 26192545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
    Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
    Bhat RV; Turner SL; Marks MJ; Collins AC
    J Pharmacol Exp Ther; 1990 Oct; 255(1):187-96. PubMed ID: 2213555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
    Nuutinen S; Ahtee L; Tuominen RK
    Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.